Skip to main content
Funding

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (27${count})

  • Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006
    Evaluation of gastrointestinal motility in parkinsonian rodents

    Gastrointestinal (GI) symptoms, such as nausea, bloating, and constipation occur in nearly every patient afflicted with Parkinson's Disease (PD) at some point in their illness. These symptoms on their...

  • Clinicopathological Correlations of Parkinson’s Disease, 2009
    Evaluation of the Enteric Nervous System in PD

    Objective/Rationale:
    Gastrointestinal (GI) symptoms (constipation, for example) afflict essentially every PD patient, negatively impact quality of life, and diminish effectiveness of oral medications...

  • Research Grant, 2022
    Undiagnosed Parkinson’s in the Emergency Department: An Opportunity for Early Intervention

    Study Rationale: Many patients diagnosed with Parkinson’s disease had signs or symptoms of the disease years before an actual diagnosis is made. An astonishingly high percentage of these patients are...

  • Spring 2022 RFP: Proof-of-Concept Testing of PD Therapeutics, 2022
    Preclinical Models and Therapies for the Gastrointestinal Symptoms of Parkinson’s Disease

    Study Rationale: In addition to the well-recognized movement abnormalities associated with Parkinson’s disease (PD), gastrointestinal symptoms such as constipation, leaky gut and inflammation are also...

  • Research Grant, 2023
    Leveraging Gene Expression Data to Redefine Parkinson’s Disease and the Pathways Driving Disease in Different Individuals

    Study Rationale: People with Parkinson’s disease (PD) share some common problems, such as stiffness, slowness of movement and tremors. However, these symptoms vary in severity, and individuals often...

  • Improved Biomarkers and Clinical Outcome Measures, 2021
    Isolating Olfactory Biomarkers of Early Parkinson’s Disease

    Study Rationale:
    Recently, researchers discovered a specific set of molecules in the oily substance produced by the skin of people with Parkinson’s disease (PD). The findings stemmed from work with a...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.